Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMPH – Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc.
AMPH
$21.21
Name : Amphastar Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $1,000,291,136.00
EPSttm : 2.76
finviz dynamic chart for AMPH
Amphastar Pharmaceuticals, Inc.
$21.21
1.24%
$0.26

Float Short %

11.59

Margin Of Safety %

39

Put/Call OI Ratio

0.22

EPS Next Q Diff

0.08

EPS Last/This Y

-0.16

EPS This/Next Y

0.39

Price

21.21

Target Price

32.2

Analyst Recom

2.33

Performance Q

-11.18

Relative Volume

0.86

Beta

0.76

Ticker: AMPH




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04AMPH23.20.530.00647
2025-07-07AMPH22.830.530.00647
2025-07-08AMPH22.60.520.00655
2025-07-09AMPH22.430.480.25695
2025-07-10AMPH22.220.480.00699
2025-07-11AMPH21.650.480.50700
2025-07-14AMPH22.040.480.00705
2025-07-15AMPH21.180.460.00726
2025-07-16AMPH21.270.420.60777
2025-07-17AMPH21.70.421.33793
2025-07-18AMPH20.620.440.42808
2025-07-21AMPH21.180.300.17901
2025-07-22AMPH21.330.300.33905
2025-07-23AMPH22.620.300.02908
2025-07-24AMPH22.510.270.00983
2025-07-25AMPH22.360.240.251099
2025-07-28AMPH22.230.240.071102
2025-07-29AMPH21.680.230.001156
2025-07-30AMPH21.360.220.001204
2025-07-31AMPH20.970.220.001205
2025-08-01AMPH21.210.220.001210
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04AMPH23.20-21.2- 3.12
2025-07-07AMPH22.84-21.2- 3.12
2025-07-08AMPH22.60-21.2- 3.12
2025-07-09AMPH22.44-21.2- 3.12
2025-07-10AMPH22.21-21.2- 3.12
2025-07-11AMPH21.66-21.2- 3.12
2025-07-14AMPH21.95-21.2- 3.12
2025-07-15AMPH21.18-21.2- 3.12
2025-07-16AMPH21.26-21.2- 3.12
2025-07-17AMPH21.70-21.2- 3.12
2025-07-18AMPH20.62-21.2- 3.12
2025-07-21AMPH21.19-21.2- 3.12
2025-07-22AMPH21.34-21.2- 3.12
2025-07-23AMPH22.63-21.2- 3.12
2025-07-24AMPH22.51-21.2- 3.12
2025-07-25AMPH22.37-21.2- 3.12
2025-07-28AMPH22.21-21.1- 3.13
2025-07-29AMPH21.67-21.1- 3.13
2025-07-30AMPH21.34-21.1- 3.13
2025-07-31AMPH20.95-21.1- 3.13
2025-08-01AMPH21.21-21.1- 3.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04AMPH-0.06-5.0711.80
2025-07-07AMPH-0.06-5.0911.80
2025-07-08AMPH-0.06-5.0911.80
2025-07-09AMPH-0.06-5.0911.80
2025-07-10AMPH-0.06-5.0911.80
2025-07-11AMPH-0.06-5.0911.75
2025-07-14AMPH-0.06-4.9911.75
2025-07-15AMPH-0.06-4.9911.75
2025-07-16AMPH-0.06-4.9911.75
2025-07-17AMPH-0.06-4.9911.75
2025-07-18AMPH-0.06-4.9911.75
2025-07-21AMPH-0.06-4.3011.75
2025-07-22AMPH-0.06-4.3011.75
2025-07-23AMPH-0.06-4.3011.75
2025-07-24AMPH-0.06-4.3011.75
2025-07-25AMPH-0.06-4.3011.58
2025-07-28AMPH-0.06-4.4411.59
2025-07-29AMPH-0.06-4.4411.59
2025-07-30AMPH-0.06-4.4411.59
2025-07-31AMPH-0.06-4.4411.59
2025-08-01AMPH-0.06-4.4411.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.74

Avg. EPS Est. Current Quarter

0.74

Avg. EPS Est. Next Quarter

0.82

Insider Transactions

-0.06

Institutional Transactions

-4.44

Beta

0.76

Average Sales Estimate Current Quarter

173

Average Sales Estimate Next Quarter

185

Fair Value

29.53

Quality Score

89

Growth Score

92

Sentiment Score

21

Actual DrawDown %

68.7

Max Drawdown 5-Year %

-68.3

Target Price

32.2

P/E

7.7

Forward P/E

6.02

PEG

P/S

1.37

P/B

1.35

P/Free Cash Flow

6.66

EPS

2.76

Average EPS Est. Cur. Y​

3.13

EPS Next Y. (Est.)

3.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.38

Relative Volume

0.86

Return on Equity vs Sector %

-4.9

Return on Equity vs Industry %

11

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Amphastar Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 2028
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging, as well as Albuterol Sulfate inhalation aerosol. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
stock quote shares AMPH – Amphastar Pharmaceuticals Inc Stock Price stock today
news today AMPH – Amphastar Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch AMPH – Amphastar Pharmaceuticals Inc yahoo finance google finance
stock history AMPH – Amphastar Pharmaceuticals Inc invest stock market
stock prices AMPH premarket after hours
ticker AMPH fair value insiders trading